<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>GHB - Complete Profile</title>
    <link rel="stylesheet" href="/Dyo-s-Dubious-Domain/style.css">
    <link rel="icon" type="image/svg+xml" href="/Dyo-s-Dubious-Domain/assets/logo.svg">
    <script>
        // Set base path for JavaScript files to use
        window.SITE_BASE_PATH = '/Dyo-s-Dubious-Domain/';
    </script>
</head>

<body class="
  
  
  
  ">
    <header class="page-header">
  <div class="container">
    <div class="page-header__content">
      <div class="logo-container">
        <a href="/Dyo-s-Dubious-Domain/" class="site-title">Dyo's Dubious Domain</a>
      </div>
      
      <nav>
        <ul role="list" class="nav-list flex-group">
          <li>
            <a href="/Dyo-s-Dubious-Domain/">Home</a>
          </li>
          <li>
            <a href="/Dyo-s-Dubious-Domain/dyos-domain/">Dyo's Domain</a>
          </li>
          <li>
            <a href="/Dyo-s-Dubious-Domain/about/">About</a>
          </li>
          <li>
            <a href="/Dyo-s-Dubious-Domain/profile/">My Profile</a>
          </li>
         
        </ul>
      </nav>
    </div>
    
    <!-- Search Bar - Now underneath header -->
    <div class="search-container">
      <input type="text" id="search-input" placeholder="Search substances..." class="search-input" />
      <div id="search-results" class="search-results" style="display: none;"></div>
    </div>
  </div>
</header>

    <main>
      
<div class="substance-profile-header">
  <div class="container">
    <nav class="breadcrumb">
      <a href="/dyos-domain/">Dyo's Domain</a> ‚Üí <a href="/dyos-domain/depressants/">Depressants</a> ‚Üí <span>GHB</span>
    </nav>
    
    <div class="substance-hero">
      <div class="substance-info">
        <h1>üåô GHB</h1>
        <h2 class="chemical-name">Gamma-Hydroxybutyric Acid</h2>
         <!-- Add to Profile Button -->
        <button id="add-to-profile-btn" class="add-to-profile-btn not-in-profile" 
                data-substance="GHB" 
                data-category="Depressants" 
                data-chemical="Gamma-Hydroxybutyric Acid">
          + Add to My Profile
        </button>
        
        <div class="alternative-names">
          <h3>Alternative Names & Slang</h3>
          <div class="names-grid">
            <div class="name-category">
              <h4>Common Names</h4>
              <span>GHB</span> ‚Ä¢ <span>Gamma-OH</span> ‚Ä¢ <span>Liquid Ecstasy</span> ‚Ä¢ <span>Liquid X</span>
            </div>
            <div class="name-category">
              <h4>Street Names</h4>
              <span>G</span> ‚Ä¢ <span>Gina</span> ‚Ä¢ <span>Georgia Home Boy</span> ‚Ä¢ <span>Grievous Bodily Harm</span> ‚Ä¢ <span>Goopy</span>
            </div>
            <div class="name-category">
              <h4>Medical Names</h4>
              <span>Sodium Oxybate</span> ‚Ä¢ <span>Xyrem</span> ‚Ä¢ <span>Sodium GHB</span> ‚Ä¢ <span>Alcover</span>
            </div>
            <div class="name-category">
              <h4>Chemical Names</h4>
              <span>4-Hydroxybutanoic acid</span> ‚Ä¢ <span>Œ≥-Hydroxybutyric acid</span> ‚Ä¢ <span>GHB sodium salt</span>
            </div>
          </div>
        </div>
        
        <div class="substance-meta-large">
          <span class="category depressant">Depressant</span>
          <span class="legal-status controlled">Schedule I/III</span>
          <span class="duration short">2-4 hours</span>
          <span class="danger-level high">NARROW SAFETY MARGIN</span>
        </div>
      </div>
      
      <div class="substance-visual">
        <div class="substance-image">
          <img src="/assets/substances/ghb.jpg" alt="GHB liquid and molecular structure" class="substance-photo">
        </div>
        <div class="molecule-structure">
          <div class="structure-placeholder">
            <p>üß¨ C‚ÇÑH‚ÇàO‚ÇÉ</p>
            <p>MW: 104.11 g/mol</p>
            <p>‚ö†Ô∏è ENDOGENOUS</p>
          </div>
        </div>
      </div>
    </div>
  </div>
</div>

<div class="container">
  
  <div class="profile-grid">
    
    <div class="profile-section identification">
      <h3>üîç Physical Identification</h3>
      <div class="identification-info">
        <div class="pure-form">
          <h4>Pure GHB (Sodium Salt)</h4>
          <ul>
            <li><strong>Appearance:</strong> Clear, colorless liquid when dissolved</li>
            <li><strong>Powder form:</strong> White crystalline powder (rare)</li>
            <li><strong>Odor:</strong> Virtually odorless</li>
            <li><strong>Taste:</strong> Strongly salty, soapy, bitter aftertaste</li>
            <li><strong>Consistency:</strong> Slightly viscous, oily texture</li>
            <li><strong>Solubility:</strong> Highly soluble in water</li>
          </ul>
        </div>
        
        <div class="street-forms">
          <h4>Available Forms</h4>
          <ul>
            <li><strong>Liquid solution:</strong> Most common, usually in small bottles</li>
            <li><strong>Powder:</strong> White crystalline form requiring dissolution</li>
            <li><strong>Capsules:</strong> Pre-measured doses in gelatin caps</li>
            <li><strong>Medical Xyrem:</strong> Pharmaceutical sodium oxybate solution</li>
          </ul>
        </div>
        
        <div class="precursor-warning">
          <h4>‚ö†Ô∏è Precursor Chemicals</h4>
          <p><strong>GBL (Gamma-Butyrolactone):</strong> Converts to GHB in stomach acid</p>
          <p><strong>1,4-Butanediol:</strong> Metabolizes to GHB in liver</p>
          <p><strong>Both precursors:</strong> Similar effects but different onset/duration</p>
          <p><strong>Critical:</strong> Precursors may have different potency and timing</p>
        </div>
      </div>
    </div>
    
    <div class="profile-section dosage">
      <h3>üíä Dosage Guidelines</h3>
      <div class="dosage-warning">
        <h4>üö® CRITICAL WARNING</h4>
        <p><strong>EXTREMELY NARROW MARGIN OF SAFETY</strong> - The difference between euphoria and coma can be less than 1ml. Individual sensitivity varies dramatically. What's euphoric for one person can be fatal for another.</p>
      </div>
      
      <div class="dosage-chart">
        <div class="dose-range threshold">
          <span class="range-label">Threshold</span>
          <span class="dose-amount">0.5-1g</span>
          <div class="dose-bar"></div>
        </div>
        <div class="dose-range light">
          <span class="range-label">Light</span>
          <span class="dose-amount">1-1.5g</span>
          <div class="dose-bar"></div>
        </div>
        <div class="dose-range common">
          <span class="range-label">Common</span>
          <span class="dose-amount">1.5-2.5g</span>
          <div class="dose-bar"></div>
        </div>
        <div class="dose-range dangerous">
          <span class="range-label">DANGEROUS</span>
          <span class="dose-amount">2.5-3.5g</span>
          <div class="dose-bar"></div>
        </div>
        <div class="dose-range coma">
          <span class="range-label">COMA RISK</span>
          <span class="dose-amount">3.5g+</span>
          <div class="dose-bar"></div>
        </div>
      </div>
      
      <div class="dosage-details">
        <h4>Critical Dosing Considerations</h4>
        <ul>
          <li><strong>Individual variation:</strong> Tolerance varies 5-10x between individuals</li>
          <li><strong>Empty stomach:</strong> Effects much stronger - reduce dose by 30-50%</li>
          <li><strong>Redosing danger:</strong> Never redose - delayed onset leads to overdose</li>
          <li><strong>Alcohol interaction:</strong> Dramatically increases overdose risk</li>
          <li><strong>Tolerance paradox:</strong> Regular users often become MORE sensitive</li>
          <li><strong>Precise measurement:</strong> Use accurate scale - eyeballing can be fatal</li>
        </ul>
      </div>
      
      <p class="dosage-note"><strong>MEASUREMENT CRITICAL:</strong> Use a milligram scale. "Capfuls" and "sips" kill people. Start with 1g maximum for first time users. Wait 2+ hours before considering any additional dose.</p>
    </div>

    <div class="profile-section effects">
      <h3>‚ú® Effects Profile</h3>
      
      <div class="effects-timeline">
        <h4>Timeline (Oral)</h4>
        <div class="timeline-item">
          <span class="time">T+0:15-0:45</span>
          <span class="effect">Onset - relaxation, mild euphoria</span>
        </div>
        <div class="timeline-item">
          <span class="time">T+0:45-2:00</span>
          <span class="effect">Peak - euphoria, sociability, disinhibition</span>
        </div>
        <div class="timeline-item">
          <span class="time">T+2:00-4:00</span>
          <span class="effect">Plateau - sustained effects, possible sedation</span>
        </div>
        <div class="timeline-item">
          <span class="time">T+4:00-8:00</span>
          <span class="effect">Comedown - gradual return, possible rebound insomnia</span>
        </div>
      </div>

      <div class="effects-categories">
        <div class="effect-category positive">
          <h4>‚úÖ Positive Effects (Low Doses)</h4>
          <ul>
            <li>Euphoria and wellbeing</li>
            <li>Enhanced sociability and empathy</li>
            <li>Reduced anxiety and inhibitions</li>
            <li>Increased confidence</li>
            <li>Enhanced sensuality</li>
            <li>Deep, restful sleep (after effects)</li>
            <li>Mild stimulation paradoxically</li>
          </ul>
        </div>
        
        <div class="effect-category negative">
          <h4>‚ùå Dangerous Effects (Higher Doses)</h4>
          <ul>
            <li>Severe sedation and unconsciousness</li>
            <li>Respiratory depression</li>
            <li>Memory blackouts and amnesia</li>
            <li>Loss of motor control</li>
            <li>Nausea and vomiting</li>
            <li>Hypothermia</li>
            <li>Coma and death</li>
          </ul>
        </div>
      </div>
    </div>

    <div class="profile-section pharmacology">
      <h3>üß† Pharmacology & Neuroscience</h3>
      <div class="pharma-details">
        <h4>Primary Mechanism of Action</h4>
        <p>GHB is both an endogenous neurotransmitter and GABA-B receptor agonist. At physiological concentrations, it acts through specific GHB receptors. At pharmacological doses, it primarily activates GABA-B receptors, causing widespread CNS depression. GHB also modulates dopamine release, contributing to its rewarding properties.</p>
        
        <h4>Detailed Receptor Pharmacology</h4>
        <div class="receptor-table">
          <div class="receptor-row">
            <span class="receptor-name"><strong>GABA-B receptors</strong></span>
            <span class="affinity">High affinity at pharmacological doses</span>
            <span class="function">Primary CNS depression, sedation, euphoria</span>
          </div>
          <div class="receptor-row">
            <span class="receptor-name"><strong>GHB receptors</strong></span>
            <span class="affinity">Specific endogenous binding sites</span>
            <span class="function">Natural GHB neurotransmitter functions</span>
          </div>
          <div class="receptor-row">
            <span class="receptor-name"><strong>Dopamine system</strong></span>
            <span class="affinity">Indirect modulation</span>
            <span class="function">Reward, euphoria, addiction potential</span>
          </div>
          <div class="receptor-row">
            <span class="receptor-name"><strong>GABA-A receptors</strong></span>
            <span class="affinity">Weak, indirect effects</span>
            <span class="function">Additional CNS depression at high doses</span>
          </div>
        </div>

        <h4>Pharmacokinetics</h4>
        <div class="metabolism-details">
          <p><strong>Absorption:</strong> Rapid oral absorption, peak levels in 30-60 minutes</p>
          <p><strong>Distribution:</strong> Crosses blood-brain barrier efficiently</p>
          <p><strong>Metabolism:</strong> Metabolized to succinate via succinate semialdehyde</p>
          <p><strong>Elimination:</strong> Very short half-life (30-60 minutes)</p>
          <p><strong>Clearance:</strong> Nearly complete within 6-8 hours</p>
          <p><strong>Detection:</strong> Undetectable in standard drug tests after 12 hours</p>
        </div>

        <h4>Endogenous GHB System</h4>
        <div class="endogenous-system">
          <p><strong>Natural occurrence:</strong> Found naturally in brain, especially basal ganglia</p>
          <p><strong>Physiological roles:</strong> Sleep regulation, temperature control, memory</p>
          <p><strong>Synthesis:</strong> Made from GABA by GABA transaminase and succinate semialdehyde reductase</p>
          <p><strong>Circadian rhythm:</strong> Natural GHB levels fluctuate with sleep-wake cycle</p>
        </div>

        <h4>Unique Pharmacological Properties</h4>
        <ul>
          <li><strong>Biphasic effects:</strong> Stimulating at low doses, sedating at high doses</li>
          <li><strong>Rapid tolerance:</strong> Develops within days of regular use</li>
          <li><strong>Withdrawal syndrome:</strong> Potentially life-threatening seizures</li>
          <li><strong>Date rape potential:</strong> Causes amnesia and incapacitation</li>
          <li><strong>Sleep enhancement:</strong> Increases slow-wave sleep dramatically</li>
        </ul>
      </div>
    </div>

    <div class="profile-section safety">
      <h3>‚ö†Ô∏è Safety & Harm Reduction</h3>
      
      <div class="safety-grid">
        <div class="safety-item critical">
          <h4>üö® EXTREME DANGERS</h4>
          <ul>
            <li><strong>Overdose risk:</strong> Extremely narrow margin between euphoria and coma</li>
            <li><strong>Respiratory depression:</strong> Can cause breathing to stop entirely</li>
            <li><strong>Alcohol synergy:</strong> Deadly combination - dramatically increases overdose risk</li>
            <li><strong>Amnesia and incapacitation:</strong> Complete memory loss and inability to consent</li>
            <li><strong>Withdrawal seizures:</strong> Life-threatening seizures with physical dependence</li>
          </ul>
        </div>
        
        <div class="safety-item precautions">
          <h4>üõ°Ô∏è Critical Harm Reduction</h4>
          <ul>
            <li>NEVER use with alcohol or other depressants</li>
            <li>Use precise milligram scale - never eyeball doses</li>
            <li>Have sober, trusted person present who knows what you've taken</li>
            <li>Start with 1g maximum, wait 2+ hours before considering more</li>
            <li>Use only in safe environment with people you completely trust</li>
            <li>Never drive or operate machinery</li>
            <li>Avoid if you have respiratory or cardiac conditions</li>
          </ul>
        </div>
      </div>

      <div class="contraindications">
        <h4>üö´ Absolute Contraindications</h4>
        <p><strong>NEVER use if:</strong> Taking any depressants (alcohol, benzos, opioids), have respiratory conditions, heart problems, liver disease, or seizure disorders. Do not use if alone or in unfamiliar environment.</p>
      </div>

      <div class="date-rape-prevention">
        <h4>üõ°Ô∏è Sexual Assault Prevention</h4>
        <p><strong>Protect yourself and others:</strong> Never leave drinks unattended, only accept drinks from trusted sources, watch for signs of incapacitation in others. GHB causes profound amnesia and inability to consent - report suspected drugging immediately.</p>
      </div>
    </div>

    <div class="profile-section interactions">
      <h3>‚öóÔ∏è Drug Interactions</h3>
      
      <div class="interaction-levels">
        <div class="interaction dangerous">
          <h4>üî¥ DEADLY COMBINATIONS</h4>
          <ul>
            <li><strong>Alcohol:</strong> Most dangerous combination - dramatically increases overdose risk</li>
            <li><strong>Benzodiazepines:</strong> Synergistic CNS depression, respiratory failure</li>
            <li><strong>Opioids:</strong> Additive respiratory depression, high death risk</li>
            <li><strong>Barbiturates:</strong> Extreme CNS depression, coma risk</li>
          </ul>
        </div>
        
        <div class="interaction risky">
          <h4>üü° High Risk</h4>
          <ul>
            <li><strong>Antihistamines:</strong> Enhanced sedation, increased overdose risk</li>
            <li><strong>Sleep medications:</strong> Additive CNS depression</li>
            <li><strong>Muscle relaxants:</strong> Increased respiratory depression</li>
            <li><strong>Antipsychotics:</strong> Enhanced sedation</li>
          </ul>
        </div>
        
        <div class="interaction caution">
          <h4>üü† Use Extreme Caution</h4>
          <ul>
            <li><strong>Stimulants:</strong> May mask GHB effects, increasing overdose risk</li>
            <li><strong>Cannabis:</strong> May increase sedation and memory impairment</li>
            <li><strong>Dissociatives:</strong> Unpredictable interactions, increased confusion</li>
            <li><strong>Any CNS active drugs:</strong> Potential for dangerous interactions</li>
          </ul>
        </div>
      </div>
    </div>

    <div class="profile-section legal">
      <h3>‚öñÔ∏è Legal Status</h3>
      <div class="legal-info">
        <div class="legal-jurisdictions">
          <div class="jurisdiction">
            <h4>üá∫üá∏ United States</h4>
            <p><strong>Schedule I (illegal)</strong> - Up to 20 years prison for trafficking. <strong>Schedule III as Xyrem</strong> - Legal by prescription for narcolepsy.</p>
          </div>
          <div class="jurisdiction">
            <h4>üá¨üáß United Kingdom</h4>
            <p><strong>Class C</strong> - Up to 2 years for possession, 14 years for supply. Legal as licensed medicine.</p>
          </div>
          <div class="jurisdiction">
            <h4>üá¶üá∫ Australia</h4>
            <p><strong>Schedule 9</strong> - Prohibited except for approved medical/research use. Severe penalties for possession.</p>
          </div>
          <div class="jurisdiction">
            <h4>üá™üá∫ European Union</h4>
            <p><strong>Controlled</strong> - Varies by country, generally illegal except for medical use. Severe penalties in most jurisdictions.</p>
          </div>
        </div>
        
        <div class="medical-status">
          <h4>üè• Medical Applications</h4>
          <p><strong>Xyrem (Sodium Oxybate):</strong> FDA-approved for narcolepsy and cataplexy. Highly regulated - requires special pharmacy program due to abuse potential.</p>
          <p><strong>Alcover:</strong> Used in some countries for alcohol withdrawal and maintenance.</p>
        </div>
      </div>
    </div>

    <div class="profile-section history">
      <h3>üìö History & Medical Development</h3>
      
      <div class="history-timeline">
        <div class="history-event">
          <span class="year">1874</span>
          <p>First synthesized by Russian chemist Alexander Zaitsev</p>
        </div>
        <div class="history-event">
          <span class="year">1960s</span>
          <p>Developed as anesthetic in France - found to have narrow therapeutic window</p>
        </div>
        <div class="history-event">
          <span class="year">1970s</span>
          <p>Discovered as endogenous neurotransmitter in mammalian brain</p>
        </div>
        <div class="history-event">
          <span class="year">1980s</span>
          <p>Popular in bodybuilding for alleged growth hormone release</p>
        </div>
        <div class="history-event">
          <span class="year">1990s</span>
          <p>Emerges in club scene as "liquid ecstasy," date rape cases reported</p>
        </div>
        <div class="history-event">
          <span class="year">2000</span>
          <p>Emergency scheduled in US due to overdoses and sexual assaults</p>
        </div>
        <div class="history-event">
          <span class="year">2002</span>
          <p>FDA approves Xyrem for narcolepsy despite Schedule I status</p>
        </div>
      </div>

      <div class="cultural-impact">
        <h4>Club Culture and Abuse</h4>
        <p>GHB became popular in 1990s club culture for its euphoric and disinhibiting effects, earning the nickname "liquid ecstasy." However, its narrow margin of safety led to numerous overdoses, and its amnesia-inducing properties made it a weapon for sexual predators.</p>
        
        <h4>Medical Paradox</h4>
        <p>GHB represents a unique legal paradox - simultaneously a Schedule I illegal drug and FDA-approved medication. This reflects both its dangerous abuse potential and legitimate medical applications.</p>
      </div>
    </div>

    <div class="profile-section research">
      <h3>üî¨ Current Research & Medical Uses</h3>
      
      <div class="research-areas">
        <div class="research-item">
          <h4>Narcolepsy Treatment</h4>
          <p>Xyrem remains the gold standard treatment for narcolepsy with cataplexy. It consolidates sleep and reduces daytime sleepiness more effectively than any other medication.</p>
        </div>
        
        <div class="research-item">
          <h4>Alcohol Dependence</h4>
          <p>Research shows GHB (as Alcover) can reduce alcohol cravings and withdrawal symptoms. Used in some European countries as alcohol dependence treatment.</p>
        </div>
        
        <div class="research-item">
          <h4>Sleep Disorders</h4>
          <p>Studies exploring GHB's potential for other sleep disorders due to its ability to enhance slow-wave sleep. May help with sleep fragmentation conditions.</p>
        </div>
        
        <div class="research-item">
          <h4>Fibromyalgia</h4>
          <p>Clinical trials examining GHB for fibromyalgia pain and sleep disturbances. Shows promise for improving pain and sleep quality.</p>
        </div>
      </div>

      <div class="endogenous-research">
        <h4>üß† Endogenous GHB Research</h4>
        <p>Ongoing research into GHB's natural role in brain function, particularly in sleep regulation, memory consolidation, and neuroprotection. Understanding endogenous GHB may lead to new therapeutic applications.</p>
      </div>
    </div>

  </div>

  <div class="substance-resources">
    <h3>üìñ Additional Resources</h3>
    <div class="resources-grid">
      <div class="resource-item">
        <h4>Medical Information</h4>
        <ul>
          <li><a href="https://www.xyrem.com/">Xyrem Official Site</a> - Medical prescribing information</li>
          <li><a href="https://pubmed.ncbi.nlm.nih.gov/">PubMed</a> - GHB medical research</li>
          <li><a href="https://www.narcolepsynetwork.org/">Narcolepsy Network</a> - Patient resources</li>
        </ul>
      </div>
      
      <div class="resource-item">
        <h4>Harm Reduction</h4>
        <ul>
          <li><a href="https://dancesafe.org/">DanceSafe</a> - Testing and harm reduction</li>
          <li><a href="https://psychonautwiki.org/">PsychonautWiki</a> - User experiences and safety</li>
          <li><a href="https://bluelight.org/">Bluelight</a> - Harm reduction forum</li>
        </ul>
      </div>
      
      <div class="resource-item">
        <h4>Crisis Support</h4>
        <ul>
          <li><strong>Overdose Emergency:</strong> Call 911 immediately</li>
          <li><strong>Sexual Assault Hotline:</strong> 1-800-656-HOPE (US)</li>
          <li><strong>Poison Control:</strong> 1-800-222-1222 (US)</li>
        </ul>
      </div>
    </div>
  </div>

  <div class="medical-disclaimer">
    <h3>‚öïÔ∏è Critical Safety Disclaimer</h3>
    <p><strong>EXTREMELY DANGEROUS SUBSTANCE:</strong> GHB has killed numerous people due to its narrow margin between euphoria and coma. It is frequently used to facilitate sexual assault due to its amnesia-inducing properties. This information is for educational purposes only. The difference between a euphoric dose and a fatal dose can be less than 1ml. Never use alone, never combine with alcohol, and always have someone sober present who can call for help.</p>
  </div>

</div>
    </main>
     <div class="footer-divider"></div>
<footer class="site-footer">
  
</footer>




<footer class="site-footer">
  
  </svg>
    <img src="/assets/logo.svg" alt="My Logo" class="logo">
     <p>¬© 2025 Uwaniumnya. Highly Illegal.</p>
  </footer>

  

    <!-- Search Scripts -->
    <script src="/Dyo-s-Dubious-Domain/js/lunr.min.js"></script>
    <script src="/Dyo-s-Dubious-Domain/assets/js/search.js"></script>
    <script src="/Dyo-s-Dubious-Domain/assets/js/substance-integration.js"></script>
    
    <!-- Only load profile.js on profile page -->
    
</body>
</html>